Resultados de la búsqueda 561-570 of 18173 for Ovarian

  1. Salud de la mujer Noticias de la Mayo Clinic

    Mayo Clinic Q&A: Get the facts on ovarian cancer Sept. 10, 2025, 01:33 p.m. CDT. junio 2025. Mayo Clinic researchers capture first signs of ovarian cancer ...

  2. Salud de la mujer Noticias de la Mayo Clinic

    Mayo Clinic Q&A: Get the facts on ovarian cancer Sept. 10, 2025, 01:33 p.m. CDT. junio 2025. Mayo Clinic researchers capture first signs of ovarian cancer ...

  3. Salud de la mujer Noticias de la Mayo Clinic

    Mayo Clinic Q&A: Get the facts on ovarian cancer Sept. 10, 2025, 01:33 p.m. CDT. junio 2025. Mayo Clinic researchers capture first signs of ovarian cancer ...

  4. Neurología - Ensayos clínicos - Mayo Clinic

    ... ovarian cancer, (7) advanced, unresectable clear cell kidney cancer, (8) advanced, unresectable bladder cancer, (9) advanced, unresectable lung ...

  5. Salud de la mujer - Mayo Clinic

    Mayo Clinic Q&A: Get the facts on ovarian cancer Sept. 10, 2025, 01:33 p.m. CDT. junio 2025. Mayo Clinic researchers capture first signs of ovarian cancer ...

  6. Transrectal ultrasound (TRUS) - Mayo Clinic

    This includes looking at the bladder, ovaries, rectum and uterus. TRUS also helps guide procedures to these organs. TRUS can look at parts of the female ...

  7. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to study the handling of ovarian tissue, cryopreservation technology, and oocyte maturation for female pediatric cancer patients ...

  8. Salud de la mujer Noticias de la Mayo Clinic

    Mayo Clinic Q&A: Get the facts on ovarian cancer Sept. 10, 2025, 01:33 p.m. CDT. junio 2025. Mayo Clinic researchers capture first signs of ovarian cancer ...

  9. Neurología - Ensayos clínicos - Mayo Clinic

    ... ovarian cancer, (7) advanced, unresectable clear cell kidney cancer, (8) advanced, unresectable bladder cancer, (9) advanced, unresectable lung ...

  10. Oncología (médica) - Ensayos clínicos

    Oncolytic Adenovirus Coding For TNFa And IL2 (TILT-123) With Pembrolizumab Or Pembrolizumab And Pegylated Liposomal Doxorubicin As Treatment For Ovarian Cancer.